Gastroparesis and Dumping Syndrome: Current Concepts and Management

by Stephan R. Vavricka, Thomas Greuter
Published 2019-07-01

5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?

by Hans Herfarth, Stephan R. Vavricka
Published 2021-09-01

Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68

by Thomas Greuter, Thomas Greuter, Martin C. Michel, Daniela Thomann, Harald Weigmann, Stephan R. Vavricka, Stephan R. Vavricka
Published 2020-06-01

Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

by Caroline Bähler, Stephan R. Vavricka, Alain M. Schoepfer, Beat Brüngger, Oliver Reich
Published 2017-12-01

Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study

by Caroline Bähler, Beat Brüngger, Eva Blozik, Stephan R. Vavricka, Alain M. Schoepfer
Published 2022-04-01

Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy.

by Marianne R Spalinger, Silvia Lang, Stephan R Vavricka, Michael Fried, Gerhard Rogler, Michael Scharl
Published 2013-01-01

Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational...

by Roni Weisshof, Stephan R. Vavricka, Lieven Pouillon, Fiona Braegger, Montserrat Roset, Nawal Bent-Ennakhil, Marc Ferrante
Published 2023-11-01

Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey

by Xavier Hébuterne, Stephan R Vavricka, Helen C Thorne, Lara MacKenzie-Smith, Raphaël Laoun, Johan Burisch
Published 2023-05-01

Follow-Up Ileocolonoscopy Is Underused in Crohn’s Disease Patients after Ileocecal Resection despite Higher Total and Inpatient Health-Care Costs Compared to Controls

by Stephan R. Vavricka, Thomas Greuter, Beat Brüngger, Eva Blozik, Jennifer Celeiro, Alain M. Schoepfer, Caroline Bähler
Published 2020-05-01

Multilocular Hepatic Abscess Formation and Sepsis due to Yersinia enterocolitica in a Patient with Hereditary Hemochromatosis and Type 2 Diabetes Mellitus

by Matthias Sauter, Stephan R. Vavricka, Pascal Locher, Benjamin Preiswerk, Dominik Weishaupt, Christoph A. Meier, Benjamin Misselwitz
Published 2017-11-01

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

by Luc Biedermann, Laura Renz, Nicolas Fournier, Jean-Benoît Rossel, Matthias Butter, Sena Bluemel, Stephan R. Vavricka, Gerhard Rogler, Michael Scharl
Published 2019-07-01

Regulation of the expression of chaperone gp96 in macrophages and dendritic cells.

by Lutz Wolfram, Anne Fischbeck, Isabelle Frey-Wagner, Kacper A Wojtal, Silvia Lang, Michael Fried, Stephan R Vavricka, Martin Hausmann, Gerhard Rogler
Published 2013-01-01

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.

by Marius Vögelin, Luc Biedermann, Pascal Frei, Stephan R Vavricka, Sylvie Scharl, Jonas Zeitz, Michael C Sulz, Michael Fried, Gerhard Rogler, Michael Scharl
Published 2016-01-01

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.

by Aimee Hiller, Luc Biedermann, Nicolas Fournier, Matthias Butter, Stephan R Vavricka, Adrian Ciurea, Gerhard Rogler, Michael Scharl, Swiss IBD Cohort Study Group
Published 2019-01-01

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study

by Lorenz Grob, Sena Bluemel, Luc Biedermann, Nicolas Fournier, Jean-Benoit Rossel, Stephan R. Vavricka, Jonas Zeitz, Gerhard Rogler, Andreas Stallmach, Michael Scharl
Published 2020-01-01

Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study

by Stephan R. Vavricka, Thomas Greuter, Benjamin L. Cohen, Walter Reinisch, Flavio Steinwurz, Marc Fellmann, Xiang Guo, Nervin Lawendy, Jerome Paulissen, Laurent Peyrin-Biroulet
Published 2022-05-01

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

by Nina Roth, Luc Biedermann, Nicolas Fournier, Matthias Butter, Stephan R Vavricka, Alexander A Navarini, Gerhard Rogler, Michael Scharl, Swiss IBD Cohort Study Group
Published 2019-01-01

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice

by Laura Rossier, Christoph Matter, Emanuel Burri, Tatiana Galperine, Petr Hrúz, Pascal Juillerat, Alain Schoepfer, Stephan R. Vavricka, Nadine Zahnd, Natalie Décosterd, Frank Seibold
Published 2023-08-01

Bone health in patients with inflammatory bowel disease

by Andrea Kreienbuehl, Gerhard Rogler, Burri Emanuel, Luc Biedermann, Christian Meier, Pascal Juillerat, Sophie Restellini, Peter Hruz, Stefan R. Vavricka, Daniel Aeberli, Frank Seibold
Published 2024-06-01

Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.

by Kacper A Wojtal, Gerhard Rogler, Michael Scharl, Luc Biedermann, Pascal Frei, Michael Fried, Achim Weber, Jyrki J Eloranta, Gerd A Kullak-Ublick, Stephan R Vavricka
Published 2012-01-01